Literature DB >> 14592954

Regulation of the human cholesterol 7alpha-hydroxylase gene (CYP7A1) by thyroid hormone in transgenic mice.

Victor A B Drover1, Luis B Agellon.   

Abstract

Thyroid hormones exert significant changes in the metabolism of bile acids. However, in humans, the effect of thyroid hormone on cholesterol 7alpha-hydroxylase (cyp7a), the rate- controlling enzyme in the classical bile acid biosynthetic pathway, remains poorly understood and has been difficult to study directly in vivo. Previous studies from our laboratory have shown that the activity of the human cholesterol 7alpha-hydroxylase gene promoter is repressed by T(3) in cultured cells. Accordingly, we hypothesized that T(3) would negatively regulate human CYP7A1 gene expression in vivo. We tested this hypothesis by inducing hypo- and hyperthyroidism in transgenic mice expressing the human CYP7A1 gene. Hypothyroidism did not affect the abundance of human cyp7a mRNA in transgenic mice. In hyperthyroid male mice, human cyp7a mRNA abundance was decreased. No significant change in cyp7a mRNA abundance was observed in hyperthyroid female mice. Gender differences in the amount of cholesterol and bile acids in gallbladder bile were also observed. The data indicate that thyroid hormone can repress the human CYP7A1 gene in transgenic mice, but this effect is dependent on gender in this in vivo model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14592954     DOI: 10.1210/en.2003-0993

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  20 in total

1.  Identical gene regulation patterns of T3 and selective thyroid hormone receptor modulator GC-1.

Authors:  Chaoshen Yuan; Jean Z H Lin; Douglas H Sieglaff; Steven D Ayers; Frances Denoto-Reynolds; John D Baxter; Paul Webb
Journal:  Endocrinology       Date:  2011-11-08       Impact factor: 4.736

Review 2.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

3.  Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice.

Authors:  Lisen Johansson; Mats Rudling; Thomas S Scanlan; Thomas Lundåsen; Paul Webb; John Baxter; Bo Angelin; Paolo Parini
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

4.  CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood.

Authors:  Victor A Drover; Mohammad Ajmal; Fatiha Nassir; Nicholas O Davidson; Andromeda M Nauli; Daisy Sahoo; Patrick Tso; Nada A Abumrad
Journal:  J Clin Invest       Date:  2005-04-07       Impact factor: 14.808

5.  Hepatic nuclear corepressor 1 regulates cholesterol absorption through a TRβ1-governed pathway.

Authors:  Inna Astapova; Preeti Ramadoss; Ricardo H Costa-e-Sousa; Felix Ye; Kaila A Holtz; Yingxia Li; Michele W Niepel; David E Cohen; Anthony N Hollenberg
Journal:  J Clin Invest       Date:  2014-04-08       Impact factor: 14.808

6.  Thyroid hormone induction of human cholesterol 7 alpha-hydroxylase (Cyp7a1) in vitro.

Authors:  Jan A Lammel Lindemann; Anusha Angajala; David A Engler; Paul Webb; Stephen D Ayers
Journal:  Mol Cell Endocrinol       Date:  2014-02-25       Impact factor: 4.102

7.  Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding cassette transporter 1 expression.

Authors:  Ivan Tancevski; Andreas Wehinger; Egon Demetz; Philipp Eller; Kristina Duwensee; Julia Huber; Kathrin Hochegger; Wilfried Schgoer; Catherine Fievet; Frans Stellaard; Mats Rudling; Josef R Patsch; Andreas Ritsch
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

Review 8.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

9.  The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans.

Authors:  Anders Berkenstam; Jens Kristensen; Karin Mellström; Bo Carlsson; Johan Malm; Stefan Rehnmark; Neeraj Garg; Carl Magnus Andersson; Mats Rudling; Folke Sjöberg; Bo Angelin; John D Baxter
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-26       Impact factor: 11.205

10.  Thyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptor.

Authors:  Jean Z Lin; Alexandro J Martagón; Willa A Hsueh; John D Baxter; Jan-Åke Gustafsson; Paul Webb; Kevin J Phillips
Journal:  Endocrinology       Date:  2012-10-19       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.